Company news
CalciMedica, Inc. news in 2024
CalciMedica, Inc.'s news releases, calls and decks from 2024, newest first.
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical and Corporate Updates
November 14, 2024
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
November 12, 2024
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
November 6, 2024
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
October 29, 2024
CalciMedica Announces Proposed Public Offering of Common Stock
October 29, 2024
CalciMedica Announces Pricing of Public Offering of Common Stock
October 29, 2024
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
October 27, 2024
CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
October 15, 2024
CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
August 11, 2024
CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)
July 8, 2024
CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences
July 7, 2024
CalciMedica Set to Join Russell Microcap® Index
June 30, 2024
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
June 26, 2024
CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
June 25, 2024
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
May 12, 2024
CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024
May 6, 2024
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis
April 23, 2024
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
March 27, 2024
CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
March 12, 2024
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
February 27, 2024
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury
February 12, 2024
CalciMedica Announces Private Placement of up to Approximately $55 Million
January 21, 2024
Decks in 2024
- Investor Presentation (October 2024)
Investor deck · 38 slides · Oct 30, 2024
- American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
Conference · 13 slides · October 2024
- Technical Presentation (June 2024)
Technical · 14 slides · Jun 27, 2024
- Investor Presentation (February 2024)
Investor deck · 31 slides · Feb 13, 2024